Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Osteoporosis

Free Subscription 23.05.2022 3 J Bone Miner Res 3 J Clin Endocrinol Metab 10 Osteoporos Int

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

J Bone Miner Res

1. BAILEY S, Stadelmann MA, Zysset PK, Vashishth D, et al
   Influence of Metastatic Bone Lesion Type and Tumor Origin on Human Vertebral Bone Architecture, Matrix Quality, and Mechanical Properties.
   J Bone Miner Res. 2022;37:896-907.
   PubMed         Abstract available
   
   
2. FARLAY D, Rizzo S, Dempster DW, Huang S, et al
   Bone Mineral and Organic Properties in Postmenopausal Women Treated With Denosumab for Up to 10 years.
   J Bone Miner Res. 2022;37:856-864.
   PubMed         Abstract available
   
   
3. ODA T, Jodicke AM, Robinson DE, Delmestri A, et al
   Oral bisphosphonates are associated with increased risk of severe acute kidney injury in elderly patients with complex health needs: a self-controlled case series in the UK.
   J Bone Miner Res. 2022 May 17. doi: 10.1002/jbmr.4573.
   PubMed         Abstract available
   
   

   
   J Clin Endocrinol Metab

4. COMNINOS AN, Hansen MS, Courtney A, Choudhury S, et al
   Acute Effects of Kisspeptin Administration on Bone Metabolism in Healthy Men.
   J Clin Endocrinol Metab. 2022;107:1529-1540.
   PubMed         Abstract available
   
   
5. BALEANU F, Moreau M, Charles A, Iconaru L, et al
   Fragility fractures in postmenopausal women: development of 5-year prediction models using the FRISBEE study.
   J Clin Endocrinol Metab. 2022 Feb 17. pii: 6530319. doi: 10.1210.
   PubMed         Abstract available
   
   
6. ENSRUD KE, Lui LY, Crandall CJ, Orwoll ES, et al
   Repeat Bone Mineral Density Screening Measurement and Fracture Prediction in Older Men: A Prospective Cohort Study.
   J Clin Endocrinol Metab. 2022 May 19. pii: 6589466. doi: 10.1210.
   PubMed         Abstract available
   
   

   
   Osteoporos Int

7. BELAYA Z, Melnichenko G, Golounina O, Tsoriev T, et al
   Three-year progress report of Bone Health TeleECHO Moscow: a strategy to improve the care of patients with osteoporosis and other metabolic skeletal diseases in underserved communities of Russia.
   Osteoporos Int. 2022 May 20. pii: 10.1007/s00198-022-06431.
   PubMed         Abstract available
   
   
8. KONG XK, Zhao ZY, Zhang D, Xie R, et al
   Major osteoporosis fracture prediction in type 2 diabetes: a derivation and comparison study.
   Osteoporos Int. 2022 May 18. pii: 10.1007/s00198-022-06425.
   PubMed         Abstract available
   
   
9. KONSTANTELOS N, Rzepka AM, Burden AM, Cheung AM, et al
   Fracture definitions in observational osteoporosis drug effects studies that leverage healthcare administrative (claims) data: a scoping review.
   Osteoporos Int. 2022 May 17. pii: 10.1007/s00198-022-06395.
   PubMed         Abstract available
   
   
10. ALOIA JF, Islam S
    Trabecular bone score in PODA, a Randomized Controlled Trial (RCT) in older African American Women.
    Osteoporos Int. 2022;33:1411-1412.
    PubMed        
    
    
11. JACOB JJ, Paul TV
    Romosozumab and cardiovascular safety-should we learn lessons from pioglitazone?
    Osteoporos Int. 2022;33:1397-1399.
    PubMed        
    
    
12. TOMINAGA A, Wada K, Okazaki K, Nishi H, et al
    Response to Letter. "Romosozumab and cardiovascular safety- should we learn lessons from Pioglitazone?."
    Osteoporos Int. 2022;33:1401-1402.
    PubMed        
    
    
13. COSMAN F, Kendler DL, Langdahl BL, Leder BZ, et al
    Romosozumab and antiresorptive treatment: the importance of treatment sequence.
    Osteoporos Int. 2022;33:1243-1256.
    PubMed         Abstract available
    
    
14. TSAKNAKIS K, Jackle K, Luders KA, Lorenz HM, et al
    Reduced bone mineral density in adolescents with Duchenne Muscular Dystrophy (DMD) and scoliosis.
    Osteoporos Int. 2022 May 18. pii: 10.1007/s00198-022-06416.
    PubMed         Abstract available
    
    
15. BRUELL S, Nicholls KM, Hewitson TD, Talbot AS, et al
    Reduced hip bone mineral density is associated with high levels of calciprotein particles in patients with Fabry disease.
    Osteoporos Int. 2022 May 16. pii: 10.1007/s00198-022-06420.
    PubMed         Abstract available
    
    
16. HAYDEN AC, Binkley N, Krueger D, Bernatz JT, et al
    Effect of degeneration on bone mineral density, trabecular bone score and CT Hounsfield unit measurements in a spine surgery patient population.
    Osteoporos Int. 2022 May 12. pii: 10.1007/s00198-022-06407.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Osteoporosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: